SPY762.34+1.66%QQQ695.23+3.03%BTC/USD74,311.76+0.83%DIA524.59+0.55%GLD365.49−1.05%TLT80.86−0.03%
BenzingaPremium Services
Premium Services

Events

Corporate events include conference calls, annual meetings, shareholder meetings, summits, analyst days and other scheduled company activities.

IRDM
02/24/20268:00 AM—Barclays Communications And Content SymposiumSummit3——Source
IRDM
03/03/20263:25 PM—Raymond James 47th Annual Institutional Investors ConferenceInvestor Conference3Orlando, Florida—Source
IRDM
03/09/20268:00 AM—Deutsche Bank 34th Annual Media, Internet & Telecom ConferenceCorporate Conference Presentation3Palm Beach, Florida—Source
IRDM
11/19/20258:00 AM—Deutsche Bank Global Space SummitSummit2——Source
IRDM
12/09/20258:00 AM—Raymond James Tmt And Consumer ConferenceCorporate Conference Presentation2——Source
IRDM
12/02/20258:00 AM—Bank Of America Leveraged Finance ConferenceCorporate Conference Presentation2——Source
IRDM
01/14/20254:30 PM—27th Annual Needham Growth ConferenceCorporate Conference Presentation3New York—Source
IRDM
12/09/20248:00 AM—Raymond James 2024 Tmt And Consumer ConferenceCorporate Conference Presentation3——Source
IRDM
11/20/20248:00 AM—The Deutsche Bank Global Space SummitSummit3——Source
IRDM
11/20/20248:00 AM—The 6th Annual Needham Virtual Infrastructure, Data Analytics Software & Cloud Communications ConferenceCorporate Conference Presentation3Virtual—Source
IRDM
09/24/20242:20 PM—The Deutsche Bank 32nd Annual Leveraged Finance ConferenceCorporate Conference Presentation3Scottsdale, AZ
Join Webcast
Source

Recent Corporate News

Dan Ives Says 'Irreplaceable' Nvidia CEO Jensen Huang Is the 'Central Nervous System' of US Tech, Says Company Has No Succession Plan Amid China Spy Allegations
Dan Ives Says 'Irreplaceable' Nvidia CEO Jensen Huang Is the 'Central Nervous System' of US Tech, Says Company Has No Succession Plan Amid China Spy Allegations
Analyst Dan Ives calls Nvidia CEO Jensen Huang the "irreplaceable" central nervous system of US tech amid China spy rumors and market fears.
Tesla, SpaceX Face Different Risks From Gina Hinojosa’s Texas Midterm Win: Bitunix Analyst Says Expansion, Not Existing Operations, Is Key Concern
Tesla, SpaceX Face Different Risks From Gina Hinojosa’s Texas Midterm Win: Bitunix Analyst Says Expansion, Not Existing Operations, Is Key Concern
Bitunix analyst says Tesla and SpaceX face limited immediate Texas election risk, though future expansion and permitting could be affected.
CRWV, APLD, IREN Stocks Slip as Brad Gerstner Warns Democratic Midterm Gains Could Put 10–15 GW of AI Data Center Capacity at Risk
CRWV, APLD, IREN Stocks Slip as Brad Gerstner Warns Democratic Midterm Gains Could Put 10–15 GW of AI Data Center Capacity at Risk
CoreWeave, Applied Digital and IREN slip as Brad Gerstner warns Democratic wins could delay 10-15 GW of AI data centers.
Stock Market Today: Nasdaq 100 Rebounds From OpenAI Scare, T-Mobile Tumbles 12%
Stock Market Today: Nasdaq 100 Rebounds From OpenAI Scare, T-Mobile Tumbles 12%
The Nasdaq 100 recovers from Thursday's OpenAI-driven selloff while T-Mobile sinks 12% on SpaceX's spectrum deal and the 10-year yield holds near 5.26%.
Jim Cramer Says Meta Must Be Seen as an ‘Enterprise Company’ as Muse AI Could Drive an '18 Times Multiple' to 24-25x
Jim Cramer Says Meta Must Be Seen as an ‘Enterprise Company’ as Muse AI Could Drive an '18 Times Multiple' to 24-25x
Jim Cramer says Meta is now an "enterprise company" due to Muse, predicting its stock multiple could jump from 18x to 24-25x.
Why is Moderna (MRNA) Stock Trending After Hours?
Why is Moderna (MRNA) Stock Trending After Hours?
Moderna shares rose 0.09% after hours Thursday as investors eyed upcoming oncology data at a major European conference.
Apple’s Foldable iPhone Could Trigger a Massive 'Upgrade Cycle,' Says Gary Black — But This One Problem Could Cap 'Incremental Earnings' for 6 Months
Apple’s Foldable iPhone Could Trigger a Massive 'Upgrade Cycle,' Says Gary Black — But This One Problem Could Cap 'Incremental Earnings' for 6 Months
Gary Black predicts Apple's foldable phone will drive a new upgrade cycle but hamper incremental earnings for 6 months.
Medicare’s $2,000 Drug Cap Is Getting Expensive — More Than 1 in 5 Seniors Hit It as Drug Spending Heads Toward $346 Billion
Medicare’s $2,000 Drug Cap Is Getting Expensive — More Than 1 in 5 Seniors Hit It as Drug Spending Heads Toward $346 Billion
Medicare drug spending faces fresh pressure as more seniors hit the $2,000 cap, raising concerns over costs.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved